Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study - BCAPS

Description:

The Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) was a randomized, double-blind, placebo-controlled trial designed to assess the effects of low-dose, once-daily metoprolol and fluvastatin on the progression of carotid intima-media thickness (IMT) in patients with carotid plaque without symptoms of carotid artery disease.